European Pharmaceutical Review
APRIL 8, 2024
A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 15, 2023
According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The structure of quinoline is represented by the fusion of benzene ring with pyridine at two neighbouring carbon atoms.
Pharmaceutical Technology
MARCH 14, 2023
These compounds cause their therapeutic effect by inhibiting DNA synthesis. GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
Pharmaceutical Technology
MARCH 14, 2023
Purine derivatives-based cancer drug compositions is a key innovation area in chemotherapy Purine is an important heterocyclic nucleus in the chemical architecture of many bioactive compounds. Among its key functions, it interacts with nucleic acids and enzymes during their synthesis and function.
Pharmaceutical Technology
APRIL 18, 2023
Innovation S-curve for the pharmaceutical industry Glycoside hydrolase-based drug compositions is a key innovation area in pharmaceuticals Glycoside hydrolases are enzymes, which hydrolyse the glycosidic linkage between two or more carbohydrates or between carbohydrates and a non-carbohydrate moiety.
pharmaphorum
MARCH 19, 2021
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. Follow him on Twitter or connect with him on LinkedIn.
Expert insights. Personalized for you.
52 
Let's personalize your content